Regulation of multidrug resistance by microRNAs in anti-cancer therapy

Multidrug resistance (MDR) remains a major clinical obstacle to successful cancer treatment. Although diverse mechanisms of MDR have been well elucidated, such as dysregulation of drugs transporters, defects of apoptosis and autophagy machinery, alterations of drug metabolism and drug targets, disru...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Xin, Sarmiento, Cesar, Tan, Tao, Zhu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237711/
https://www.ncbi.nlm.nih.gov/pubmed/28119807
http://dx.doi.org/10.1016/j.apsb.2016.09.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5237711/
https://www.ncbi.nlm.nih.gov/pubmed/28119807
http://dx.doi.org/10.1016/j.apsb.2016.09.002

Ejemplares similares